Literature DB >> 22308030

Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activity and protein translation under acute hypoxia.

Antonio Romero-Ruiz1, Lucía Bautista, Virginia Navarro, Antonio Heras-Garvín, Rosana March-Díaz, Antonio Castellano, Raquel Gómez-Díaz, María J Castro, Edurne Berra, José López-Barneo, Alberto Pascual.   

Abstract

Early adaptive responses to hypoxia are essential for cell survival, but their nature and underlying mechanisms are poorly known. We have studied the post-transcriptional changes in the proteome of mammalian cells elicited by acute hypoxia and found that phosphorylation of eukaryotic elongation factor 2 (eEF2), a ribosomal translocase whose phosphorylation inhibits protein synthesis, is under the precise and reversible control of O(2) tension. Upon exposure to hypoxia, phosphorylation of eEF2 at Thr(56) occurred rapidly (<15 min) and resulted in modest translational arrest, a fundamental homeostatic response to hypoxia that spares ATP and thus facilitates cell survival. Acute inhibitory eEF2 phosphorylation occurred without ATP depletion or AMP kinase activation. Furthermore, eEF2 phosphorylation was mimicked by prolyl hydroxylase (PHD) inhibition with dimethyloxalylglycine or by selective PHD2 siRNA silencing but was independent of hypoxia-inducible factor α stabilization. Moreover, overexpression of PHD2 blocked hypoxic accumulation of phosphorylated eEF2. Therefore, our findings suggest that eEF2 phosphorylation status (and, as a consequence, translation rate) is controlled by PHD2 activity. They unravel a novel pathway for cell adaptation to hypoxia that could have pathophysiologic relevance in tissue ischemia and cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22308030      PMCID: PMC3308822          DOI: 10.1074/jbc.M111.299180

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Management of cellular energy by the AMP-activated protein kinase system.

Authors:  D Grahame Hardie; John W Scott; David A Pan; Emma R Hudson
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

2.  Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia.

Authors:  Kenneth J D Lang; Andreas Kappel; Gregory J Goodall
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

3.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.

Authors:  N Masson; C Willam; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

6.  Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.

Authors:  Constantinos Koumenis; Christine Naczki; Marianne Koritzinsky; Sally Rastani; Alan Diehl; Nahum Sonenberg; Antonis Koromilas; Bradly G Wouters
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

Review 7.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

Authors:  M Höckel; P Vaupel
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

8.  HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.

Authors:  Edurne Berra; Emmanuel Benizri; Amandine Ginouvès; Véronique Volmat; Danièle Roux; Jacques Pouysségur
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

9.  A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

Authors:  Andrew M Arsham; Jessica J Howell; M Celeste Simon
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

10.  Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis.

Authors:  Sandrine Horman; Gareth Browne; Ulrike Krause; Jigna Patel; Didier Vertommen; Luc Bertrand; Alain Lavoinne; Louis Hue; Christopher Proud; Mark Rider
Journal:  Curr Biol       Date:  2002-08-20       Impact factor: 10.834

View more
  16 in total

Review 1.  Cellular adaptation to hypoxia through hypoxia inducible factors and beyond.

Authors:  Pearl Lee; Navdeep S Chandel; M Celeste Simon
Journal:  Nat Rev Mol Cell Biol       Date:  2020-03-06       Impact factor: 94.444

2.  Hypoxia-inducible factor-1α (HIF-1α) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.

Authors:  Tingfang Yi; Evangelos Papadopoulos; Patrick R Hagner; Gerhard Wagner
Journal:  J Biol Chem       Date:  2013-05-10       Impact factor: 5.157

3.  Bacillus anthracis Prolyl 4-Hydroxylase Interacts with and Modifies Elongation Factor Tu.

Authors:  Nicholas J Schnicker; Mortezaali Razzaghi; Sanjukta Guha Thakurta; Srinivas Chakravarthy; Mishtu Dey
Journal:  Biochemistry       Date:  2017-10-19       Impact factor: 3.162

4.  Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia.

Authors:  Claire E J Moore; Halina Mikolajek; Sergio Regufe da Mota; Xuemin Wang; Justin W Kenney; Jörn M Werner; Christopher G Proud
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

5.  Dynamics of elongation factor 2 kinase regulation in cortical neurons in response to synaptic activity.

Authors:  Justin W Kenney; Oksana Sorokina; Maja Genheden; Anatoly Sorokin; J Douglas Armstrong; Christopher G Proud
Journal:  J Neurosci       Date:  2015-02-18       Impact factor: 6.167

6.  Coordinate Regulation of Ribosome and tRNA Biogenesis Controls Hypoxic Injury and Translation.

Authors:  Omar A Itani; Xuefei Zhong; Xiaoting Tang; Barbara A Scott; Jun Yi Yan; Stephane Flibotte; Yiting Lim; Andrew C Hsieh; James E Bruce; Marc Van Gilst; C Michael Crowder
Journal:  Curr Biol       Date:  2020-11-05       Impact factor: 10.834

Review 7.  Hypoxia/HIF Modulates Immune Responses.

Authors:  Yuling Chen; Timo Gaber
Journal:  Biomedicines       Date:  2021-03-05

8.  Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.

Authors:  Marie Grandjean; Alexandra Sermeus; Samuel Branders; Florence Defresne; Marc Dieu; Pierre Dupont; Martine Raes; Mark De Ridder; Olivier Feron
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

9.  Hypoxia represses microRNA biogenesis proteins in breast cancer cells.

Authors:  Veronika Bandara; Michael Z Michael; Jonathan M Gleadle
Journal:  BMC Cancer       Date:  2014-07-22       Impact factor: 4.430

10.  Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation.

Authors:  John S Scotti; Ivanhoe K H Leung; Wei Ge; Michael A Bentley; Jordi Paps; Holger B Kramer; Joongoo Lee; WeiShen Aik; Hwanho Choi; Steinar M Paulsen; Lesley A H Bowman; Nikita D Loik; Shoichiro Horita; Chia-hua Ho; Nadia J Kershaw; Christoph M Tang; Timothy D W Claridge; Gail M Preston; Michael A McDonough; Christopher J Schofield
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.